Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer ; volume:21 ; number:1 ; day:26 ; month:7 ; year:2023 ; pages:1-13 ; date:12.2023
Journal of translational medicine ; 21, Heft 1 (26.7.2023), 1-13, 12.2023
- Creator
-
Tsai, Kuei-Yen
Chang, Yu-Jia
Huang, Chien-Yu
Prince, G. M. Shazzad Hossain
Chen, Hsin-An
Makondi, Precious Takondwa
Shen, Ying-Rou
Wei, Po-Li
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-023-04363-5
- URN
-
urn:nbn:de:101:1-2023102710420671062774
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tsai, Kuei-Yen
- Chang, Yu-Jia
- Huang, Chien-Yu
- Prince, G. M. Shazzad Hossain
- Chen, Hsin-An
- Makondi, Precious Takondwa
- Shen, Ying-Rou
- Wei, Po-Li
- SpringerLink (Online service)
Other Objects (12)
Plasma N-glycans in colorectal cancer risk
Expediting Glycospace Exploration: Therapeutic Glycans via Automated Synthesis
Expediting Glycospace Exploration: Therapeutic Glycans via Automated Synthesis
Targeting the glycans of the HIV envelope as a therapeutic tool
Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
Towards vaccines and therapeutic antibodies against Clostridium difficile based on synthetic glycans
Inflammasome inhibitors: promising therapeutic approaches against cancer
RFX1: a promising therapeutic arsenal against cancer
IUPAC HELM Glycans Extension
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Plasma N-glycans in colorectal cancer risk
Expediting Glycospace Exploration: Therapeutic Glycans via Automated Synthesis
Expediting Glycospace Exploration: Therapeutic Glycans via Automated Synthesis
Targeting the glycans of the HIV envelope as a therapeutic tool
Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
Towards vaccines and therapeutic antibodies against Clostridium difficile based on synthetic glycans
Inflammasome inhibitors: promising therapeutic approaches against cancer
RFX1: a promising therapeutic arsenal against cancer
IUPAC HELM Glycans Extension
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Plasma N-glycans in colorectal cancer risk
Expediting Glycospace Exploration: Therapeutic Glycans via Automated Synthesis
Expediting Glycospace Exploration: Therapeutic Glycans via Automated Synthesis
Targeting the glycans of the HIV envelope as a therapeutic tool
Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
Towards vaccines and therapeutic antibodies against Clostridium difficile based on synthetic glycans
Inflammasome inhibitors: promising therapeutic approaches against cancer
RFX1: a promising therapeutic arsenal against cancer
IUPAC HELM Glycans Extension